Search research articles
Contact Us
Filters
Showing results (91-100 of 256) with videos related to
Page
of 26
Sort By:
Biochemical and Biophysical Research Communications
|
July 18, 2009
Isoreserpine promotes beta-catenin degradation via Siah-1 up-regulation in HCT116 colon cancer cells
Jungsug Gwak, Taeyun Song, Jie-Young Song, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 28, 2023
CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor
Hee Young Cho, Sangzin Ahn, Yong-Soon Cho, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
April 10, 2018
Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE)
Woo-Young Kim, Su-Jun Lee, Jungki Min, et al.
Drug Metabolism and Pharmacokinetics
|
July 9, 2021
A physiologically based pharmacokinetic/pharmacodynamic modeling approach for drug-drug interaction evaluation of warfarin enantiomers with sorafenib
Ziteng Wang, Xiaoqiang Xiang, Shuaibing Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 13, 2007
Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations
Eun-Young Kim, Doo-Yeoun Cho, Ho-Jung Shin, et al.
Hepatology (Baltimore, Md.)
|
July 31, 2008
Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity
Sang Seop Lee, Eun-Young Cha, Hyun-Ju Jung, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 26, 2011
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5
Kyung-Ah Seo, So-Jeong Lee, Kwon-Bok Kim, et al.
Journal of Toxicology and Environmental Health. Part A
|
October 25, 2014
Enantioselective N-demethylation and hydroxylation of sibutramine in human liver microsomes and recombinant cytochrome p-450 isoforms
Dhananjay D Shinde, Min-Jung Kim, Eun-Sook Jeong, et al.
Journal of Clinical Pharmacology
|
January 29, 2019
Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3
Phuong Thi Thu Nguyen, Md Masud Parvez, Min Jung Kim, et al.
Toxicology Letters
|
July 22, 2006
Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028
Hyojin Kim, Yune-Jung Yoon, Hyunmi Kim, et al.
Page
of 26
Search research articles
Search
Showing results (91-100 of 256) with videos related to
Sort By:
Page
of 26
Biochemical and Biophysical Research Communications
|
July 18, 2009
Isoreserpine promotes beta-catenin degradation via Siah-1 up-regulation in HCT116 colon cancer cells
Jungsug Gwak, Taeyun Song, Jie-Young Song, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 28, 2023
CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor
Hee Young Cho, Sangzin Ahn, Yong-Soon Cho, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
April 10, 2018
Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE)
Woo-Young Kim, Su-Jun Lee, Jungki Min, et al.
Drug Metabolism and Pharmacokinetics
|
July 9, 2021
A physiologically based pharmacokinetic/pharmacodynamic modeling approach for drug-drug interaction evaluation of warfarin enantiomers with sorafenib
Ziteng Wang, Xiaoqiang Xiang, Shuaibing Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 13, 2007
Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations
Eun-Young Kim, Doo-Yeoun Cho, Ho-Jung Shin, et al.
Hepatology (Baltimore, Md.)
|
July 31, 2008
Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity
Sang Seop Lee, Eun-Young Cha, Hyun-Ju Jung, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 26, 2011
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5
Kyung-Ah Seo, So-Jeong Lee, Kwon-Bok Kim, et al.
Journal of Toxicology and Environmental Health. Part A
|
October 25, 2014
Enantioselective N-demethylation and hydroxylation of sibutramine in human liver microsomes and recombinant cytochrome p-450 isoforms
Dhananjay D Shinde, Min-Jung Kim, Eun-Sook Jeong, et al.
Journal of Clinical Pharmacology
|
January 29, 2019
Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3
Phuong Thi Thu Nguyen, Md Masud Parvez, Min Jung Kim, et al.
Toxicology Letters
|
July 22, 2006
Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028
Hyojin Kim, Yune-Jung Yoon, Hyunmi Kim, et al.
Page
of 26